Protective Effects and Mechanism of α-lipoic Acid in Graves' Disease Complicated with Liver Damage
1.Department of Endocrinology,the Third Affiliated Hospital of Jinzhou Medical University,Jinzhou 121000,China
2.Heze Central Hospital,Heze 274000,China
*Corresponding author:CUI Xiuling,Associate chief physician;E-mail:lncxl123ok@163.com
XI Yue,WANG Yuanyuan,CUI Xiuling. Protective Effects and Mechanism of α-lipoic Acid in Graves' Disease Complicated with Liver Damage[J]. Chinese General Practice, 2019, 22(8): 931-935. DOI: 10.12114/j.issn.1007-9572.2018.00.277.
奚悦,王园媛,崔秀玲. α-硫辛酸在Graves'病合并肝损伤中的保护作用及机制研究[J]. 中国全科医学, 2019, 22(8): 931-935. DOI: 10.12114/j.issn.1007-9572.2018.00.277.
[1]WANG R,TAN J,ZHANG G,et al.Risk factors of hepatic dysfunction in patients with Graves' hyperthyroidism and the efficacy of 131iodine treatment[J].Medicine(Baltimore),2017,96(5):e6035.DOI:10.1097/MD.0000000000006035.
[2]GIRIS M,ERBIL Y,DEPBOYLU B,et al.Heme oxygenase-1 prevents hyperthyroidism induced hepatic damage via an antioxidant and antiapoptotic pathway[J].J Surg Res,2010,164(2):266-275.DOI:10.1016/j.jss.2009.04.013.
[3]XING Z G,YU G D,QIN L,et al.Effects and mechanism of lipoic acid on beta-amyloid-intoxicated C6 glioma cells[J].Genet Mol Res,2015,14(4):13880-13888.DOI:10.4238/2015.October.29.8.
[4]葛均波,徐永健.内科学[M].8版.北京:人民卫生出版社,2013.
[5]HAMMERSTAD S S,TOMER Y.Epidemiology and genetic factors in Graves' disease and Graves' ophthalmopathy[M]//REBECCA S B.Graves' disease a comprehensive guide for clinicians.New York:Springer,2015:21-37.
[6]李花英,邱晓萍,刘小莺,等.Graves病患者血清氧化及抗氧化能力指标的观察[J].中华内分泌代谢杂志,2011,27(6):495-497.DOI:10.3760/cma.j.issn.1000-6699.2011.06.013.
LI H Y,QIU X P,LIU X Y,et al.Observation of serum oxidative and antioxidative indices in patients with Graves' disease[J].Chinese Journal of Endocrinology and Metabolism,2011,27(6):495-497.DOI:10.3760/cma.j.issn.1000-6699.2011.06.013.
[7]KHAN T M,MALIK S,DIJU I U.Correlation between plasmathyroidhormonesand liver enzymes level in thyrotoxic cases andcontrols in Hazara Division[J].J Ayub Med Coll Abbottabad,2010,22(2):176-179.
[8]LI C,TAN J,ZHANG G,et al.Risk factors of hyperthyroidism with hepatic function injury:a 4-year retrospective study[J].Horm Metab Res,2015,47(3):209-213.DOI:10.1055/s-0034-1375690.
[9]LIN T Y,SHEKAR A O,LI N,et al.Incidence of abnormal liver biochemical tests in hyperthyroidism[J].Clin Endocrinol(Oxf),2017,86(5):755-759.DOI:10.1111/cen.13312.
[10]梁凌云.Graves病患者维生素D的营养状况及其与甲状腺自身抗体滴度之间的关系[D].长沙:中南大学,2013.
[11]吴娟.甲巯咪唑与糖皮质激素联合治疗甲状腺功能亢进症合并症的临床疗效观察[D].银川:宁夏医科大学,2015.
[12]陈婧,胡蕴,毛晓明.氧化应激在Graves病中的研究进展[J].医学研究生学报,2014,27(6):659-664.
CHEN J,HU Y,MAO X M.Progress in research on oxidative stress in Graves disease[J].Journal of Medical Postgraduates,2014,27(6):659-664.
[13]BURCH H B,COOPER D S.Management of Graves'disease:a review[J].JAMA,2015,314(23):2544-2554.DOI:10.1001/jama.2015.16535.
[14]PETERSEN SHAI K,MOREAU R F,SMITH E J,et al.Is alpha-lipoic acid ascavenger of reactive oxygen species in vivo?Evidence for its initiation of stress signaling pathways that promote endogenousantioxidant capacity[J].IUBMB Life,2008,60(6):362-367.DOI:10.1002/iub.40.
[15]王新容.α-硫辛酸的临床应用概况[J].海峡药学,2013,25(8):18-19.DOI:10.3969/j.issn.1006-3765.2013.08.005.
WANG X R.Clinical application of α-lipoic acid[J].Strait Pharmaceutical Journal,2013,25(8):18-19.DOI:10.3969/j.issn.1006-3765.2013.08.005.
[16]KORIYAMA Y,NAKAYAMA Y.Protective effect of lipoic acid against oxidative stress ismediated by Keap1/Nrf2-dependent heme oxygenase-1induction in the RGC-5 cell line[J].Brain Res,2013,1499:145-157.DOI:10.1016/j.brainres.2012.12.041.